InvestorsHub Logo
Followers 15
Posts 542
Boards Moderated 0
Alias Born 01/13/2006

Re: None

Thursday, 01/09/2014 5:22:43 PM

Thursday, January 09, 2014 5:22:43 PM

Post# of 3360
Maxim Reiterates Buy with $1.50 price target

The full Maxim coverage report dated Jan 8, 2014 can be found on Isoray website under Investors...Analyst Coverage .

New product added to commercial portfolio; Reiterating
Buy and $1.50 price target
Yesterday, ISR announced that the FDA cleared liquid
cesium-131 for use in the company’s GliaSite radiation
therapy system. We believe this is a step forward for ISR to
expand the cesium-131 market and drive its revenue growth
in the next few years."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CATX News